Skip to content

The Effect of Dietary Approach to Stop Hypertension (DASH) on Insulin Resistance

The Effect of DASH (Dietary Approach to Stop Hypertension) on IRS1 and PPAR?2 Genes Expression in Obese Women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014090719072N1
Enrollment
60
Registered
2015-02-11
Start date
2013-03-31
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy obese volunteer. Simple obesity NOS

Interventions

Intervention 1: The intervention group will prescribe DASH diet that is rich in fruits, vegetables, whole grains, and low fat dairy products, and low in saturated fat, total fat, cholesterol, refined
Lifestyle
The intervention group will prescribe DASH diet that is rich in fruits, vegetables, whole grains, and low fat dairy products, and low in saturated fat, total fat, cholesterol, refined grains and swee
The control group was recommended to “eat as usual” and received healthy dietary advises which would be printed on a paper .Every participant will bring his 3-day diet records every month, and the da

Sponsors

Isfahan University of Medica Science ,Deputy Director of Research and Development
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 49 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: female; Body Mass Index above 30; age 20-50; absence of cardiovascular; hepatic; renal; thyroid; diabetes; rheumatoid arthritis; lupus; severe infection; trauma; allergy disease; don't use of multivitamin and mineral or omega-3 fatty acids supplements; don't regular use of antacid drugs containing magnesium and calcium ; consumption Aspirin and Non Steroid Anti Inflammation; and anti-depressant and hormone drugs; lack of pregnancy and breastfeeding; don't get weight loss in 6 months (more than 1 kg; don't use of tobacco and alcohol. Exclusion criteria: Failure to follow the prescribed diet( energy intake is different more than 300 calorie from prescribed as regard to food record analysis ), if weight change is more than 5%, diagnosis one of mentioned disease in inclusion criteria and using of chemical or herbal medicines during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
PPAR gamma Gene Expression. Timepoint: Before Intervention and After 3 Months. Method of measurement: Real Time Polymerase Chain Reaction.;IRS1 Gene Expression. Timepoint: Before Intervention and After 3 Months. Method of measurement: Real Time Polymerase Chain Reaction.;Insulin resistance. Timepoint: Before Intervention and After 3 Months. Method of measurement: Hemostatic Model Assessment(HOMA).

Secondary

MeasureTime frame
Weight. Timepoint: Before Study and After 3 Months. Method of measurement: Scale.;Fasting Sugar. Timepoint: Before Study and After 3 Months. Method of measurement: Caloremetric.;Fasting Insulin. Timepoint: Before Study and After 3 Month. Method of measurement: Elisa Method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mohammad Hasan Entezari

Isfahan University of Medical Science

entezari@hlth.mui.ac.ir+98 31 3792 2776

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026